The role of MD-2 in the process of endotoxin recognition and signal transduction

Progress in Biochemistry and Biophysics

Volumn 34, Issue 5, 2007, Pages 460-464

  Zhong, Tian Yu ^a   Liu, Jing Hua ^a   Jiang, Yong ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Lipopolysaccharide (LPS); Myeloid differentiation 2 (MD 2); Signal transduction; Toll like receptor 4 (TLR4)

Indexed keywords

EID: 34547725588     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Shimazu R, Akashi S, Ogata H, et al. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med, 1999, 189 (11): 1777-1782
2. Visintin A, Mazzoni A, Spitzer JA, et al. Secreted MD-2 is a large polymeric protein that efficiently confers lipopolysaccharide sensitivity to Toll-like receptor4. Proc Natl Acad Sci USA, 2001, 98 (21): 12156-12161
3. Gruber A, Mancek M, Wagner H, et al. Structural model of MD-2 and functional role of its basic amino acid clusters involved in cellular lipopolysaccharide recognition. J Biol Chem, 2004, 279 (27): 28475-28482
4. Re F, Strominger J L. Separate functional domains of human MD-2 mediate Toll-like receptor 4-binding and lipopolysaccharide responsiveness. J Immunol, 2003, 171 (10): 5272-5276
5. Viriyakosol S, Tobias P S, Kirkland T N, et al. Mutational analysis of membrane and soluble forms of human MD-2. J Biol Chem, 2006, 281 (17): 11955-11964
6. Mullen G E, Kennedy M N, Visintin A, et al. The role of disulfide bonds in the assembly and function of MD-2. Proc Natl Acad Sci USA, 2003, 100 (7): 3919-3924
7. Visintin A, Latz E, Monks BG, et al. Lysines 128 and 132 enable lipopolysaccharide binding to MD-2, leading to Toll-like receptor-4 aggregation and signal transduction. J Biol Chem, 2003, 278 (48): 48313-48320
8. Gangloff M, Weber AN, Gay NJ. Conserved mechanisms of signal transduction by Toll and Toll-like receptors. J Endotoxin Res, 2005, 11 (5): 294-298
9. Kobayashi M, Saitoh S, Tanimura N, et al. Regulatory roles for MD-2 and TLR4 in ligand- induced receptor clustering. J Immunol, 2006, 176(10):6211-6218
10. Nagai Y, Akashi S, Nagafuku M, et al. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat Immunol, 2002, 3 (7): 667-672
11. Liu YW, Liu JH, Tang J, et al. J South Med Univ, 2006, 26 (8): 1101-1105
12. Ohnishi T, Muroi M, Tanamoto K. MD-2 is necessary for the toll-like receptor 4 protein to undergo glycosylationessential for its translocation to the cell surface. Clin Diagn Lab Immunol, 2003, 10 (3): 405-410
13. Hyakushima N, Mitsuzawa H, Nishitani C. Interaction of soluble form of recombinant extracellular TLR4 domain with MD-2 enables lipopolysaccharide binding and attenuates TLR4-mediated signaling. J Immunol, 2004, 173 (11): 6949-6954
14. Mitsuzawa H, Nishitani C, Hyakushima N, et al. Recombinant soluble forms of extracellular TLR4 domain and MD-2 inhibit lipopolysaccharide binding on cell surface and dampen lipopolysaccharide-induced pulmonary inflammation in mice. J Immunol, 2006, 177 (11): 8133-8139
15. Saitoh S, Akashi S, Yamada T, et al. Ligand-dependent Toll-like receptor 4 (TLR4)-oligomerization is directly linked with TLR4-signaling. J Endotoxin Res, 2004, 10 (4): 257-260
16. Saitoh S, Akashi S, Yamada T, et al. Lipid A antagonist, lipid IV a, is distinct from lipid A in interaction with Toll-like receptor 4(TLR4) -MD-2 and ligand-induced TLR4 oligomerization. Int Immunol, 2004, 16 (7): 961-969
17. Rallabhandi P, Bell J, Boukhvalova MS, et al. Analysis of TLR4 polymorphic variants: new insights into TLR4/MD-2/CD14 stoichiometry, structure, and signaling. J Immunol, 2006, 177(1): 322-332
18. Pugin J, Stem-Voeffray S, Daubeuf B, et al. Soluble MD-2 activity in plasma from patients with severe sepsis and septic shock. Blood, 2004, 104 (13):4071-4079
19. Jia HP, Kline JN, Penisten A, et al. Endotoxin responsiveness ofhuman airway epithelia is limited by low expression of MD-2.Am J Physiol, 2004, 287 (2):L428-437
20. Ohta S, Bahrun U, Tanaka M, et al. Identification of a novel isoform of MD-2 that downregulates lipopolysaccharide signaling.Biochem Biophys Res Commun, 2004, 323 (3): 1103-1108
21. Divanovic S, Trompette A, Atabani SF, et al. Inhibition of TLR-4/MD-2 signaling by RP105/MD-1.J Endotoxin Res, 2005, 11 (6): 363-368